Form 4 for SUPN SUPERNUS PHARMACEUTICALS, INC.
Accepted 2024-02-26 00:00:00 ET · period of report 2024-02-22 · accession 0001104659-24-027578 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-02-26 | 2024-02-22 | SUPN | Bhatt Padmanabh P. | CSO, SVP of IP | F - Tax | $27.94 | -372 | 7,958 | -4% | -$10.4K |
| D | 2024-02-26 | 2024-02-22 | SUPN | Bhatt Padmanabh P. | CSO, SVP of IP | A - Grant | $0.00 | +750 | 8,330 | +10% | $0 |
| DM | 2024-02-26 | 2024-02-22 | SUPN | Bhatt Padmanabh P. | CSO, SVP of IP | A - Grant | $0.00 | +25.0K | 20.0K | New | $0 |
| D | 2024-02-26 | 2024-02-22 | SUPN | Bhatt Padmanabh P. | CSO, SVP of IP | D - Sale to Iss | $0.00 | -750 | 1,500 | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-22 | F | D | 372 | $27.94 | 7,958 | D | — | — | (F2) Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the RSU vesting. |
| 2 | Common | Common Stock | 2024-02-22 | A | A | 750 | $0.00 | 8,330 | D | — | — | (F1) Includes an aggregate of 415 shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan. |
| 3 | Derivative | Restricted Stock Unit | 2024-02-22 | A | A | 5,000 | $0.00 | 5,000 | D | — · — to — | 5,000 Common Stock | (F3) Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting. (F5) These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 22, 2025. |
| 4 | Derivative | Employee Stock Option (Right to Buy) | 2024-02-22 | A | A | 20,000 | $0.00 | 20,000 | D | $27.94 · — to 2034-02-22 | 20,000 Common Stock | (F6) The option vests in four equal annual installments beginning on February 22, 2025. |
| 5 | Derivative | Restricted Stock Unit | 2024-02-22 | D | D | 750 | $0.00 | 1,500 | D | — · — to — | 750 Common Stock | (F3) Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting. (F4) These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 22, 2023. |